These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37156803)

  • 1. Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii.
    Sitthisak S; Manrueang S; Khongfak S; Leungtongkam U; Thummeepak R; Thanwisai A; Burton N; Dhanoa GK; Tsapras P; Sagona AP
    Sci Rep; 2023 May; 13(1):7470. PubMed ID: 37156803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a
    Jiang L; Xu Q; Wu Y; Zhou X; Chen Z; Sun Q; Wen J
    Front Cell Infect Microbiol; 2024; 14():1351993. PubMed ID: 38524182
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced Antibacterial Activity of Acinetobacter baumannii Bacteriophage ØABP-01 Endolysin (LysABP-01) in Combination with Colistin.
    Thummeepak R; Kitti T; Kunthalert D; Sitthisak S
    Front Microbiol; 2016; 7():1402. PubMed ID: 27656173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S; Lee DW; Jin JS; Kim J
    J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysin LysMK34 of
    Abdelkader K; Gutiérrez D; Grimon D; Ruas-Madiedo P; Lood C; Lavigne R; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32709718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen
    Deng S; Xu Q; Fu Y; Liang L; Wu Y; Peng F; Gao M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.
    Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M
    J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome characterization of the novel lytic phage vB_AbaAut_ChT04 and the antimicrobial activity of its lysin peptide against Acinetobacter baumannii isolates from different time periods.
    Leungtongkam U; Kitti T; Khongfak S; Thummeepak R; Tasanapak K; Wongwigkarn J; Khanthawong S; Belkhiri A; Ribeiro HG; Turner JS; Malik DJ; Sitthisak S
    Arch Virol; 2023 Sep; 168(9):238. PubMed ID: 37660314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a glycoside hydrolase endolysin from Acinetobacter baumannii phage AbTZA1 with high antibacterial potency and novel structural features.
    Premetis GE; Stathi A; Papageorgiou AC; Labrou NE
    FEBS J; 2023 Apr; 290(8):2146-2164. PubMed ID: 36413083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and
    Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M
    Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
    Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
    Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against
    Wu M; Hu K; Xie Y; Liu Y; Mu D; Guo H; Zhang Z; Zhang Y; Chang D; Shi Y
    Front Microbiol; 2018; 9():3302. PubMed ID: 30687281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.
    Peng F; Mi Z; Huang Y; Yuan X; Niu W; Wang Y; Hua Y; Fan H; Bai C; Tong Y
    BMC Microbiol; 2014 Jul; 14():181. PubMed ID: 24996449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
    Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin.
    Lim J; Jang J; Myung H; Song M
    J Microbiol; 2022 Aug; 60(8):859-866. PubMed ID: 35614377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens.
    Blasco L; Ambroa A; Trastoy R; Bleriot I; Moscoso M; Fernández-Garcia L; Perez-Nadales E; Fernández-Cuenca F; Torre-Cisneros J; Oteo-Iglesias J; Oliver A; Canton R; Kidd T; Navarro F; Miró E; Pascual A; Bou G; Martínez-Martínez L; Tomas M
    Sci Rep; 2020 Apr; 10(1):7163. PubMed ID: 32346029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia.
    Leshkasheli L; Kutateladze M; Balarjishvili N; Bolkvadze D; Save J; Oechslin F; Que YA; Resch G
    J Glob Antimicrob Resist; 2019 Dec; 19():255-261. PubMed ID: 31100499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.